Home LiteratureArticle Details
PMID: 1063056 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Chromosomal mosaicism associated with prolonged remission in chronic myelogenous leukemia.

Cancer ·Vol. 37 ·No. 4 ·1976-04-00 ·Pages 1849-52

Golde DW, Bersch NL, Sparkes RS

Abstract

The nature of the relationship between normal stem cells and the leukemic cells of chronic myelogenous leukemia (CML) is of considerable theoretical and practical importance. We studied a patient with CML who has maintained a complete hematologic remission for eight years without therapy. Presently, the only documentable abnormality is mosaicism for the Philadelphia (Ph1) chromosome. Studies of his bone marrow in vitro revealed normal colony formation in agar and normal cellular proliferation and differentiation in liquid culture. Observations in this patient indicate that a Ph1-positive clone may coexist with normal stem cells during prolonged remission in CML and the Ph1-positive cells may not always have a growth advantage over normal cells. The culture studies further suggest that the diminished proliferative capacity of the leukemic cells was not due to in vivo host suppressive factors.

MeSH Terms
Adult Bone Marrow/ultrastructure Bone Marrow Cells Cell Division Cells, Cultured Chromosome Aberrations Chromosomes, Human, 21-22 and Y Clone Cells Humans Leukemia, Myeloid/drug therapy,genetics Lymphocytes/ultrastructure Male Mosaicism Remission, Spontaneous
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Golde D W
Bersch N L
Sparkes R S
Article Info
Journal
Cancer
Abbr.
Cancer
ISSN
0008-543X
Published
1976-04-00
Pages
1849-52
Language
English
Region
United States
NLM ID
0374236
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com